QA: Amicus Therapeutics INC in us_pharma/2017

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001178879_2018_Amicus_Therapeutics_INC.pdf

Logs

warning The stock price does not exist industry.us_generic {}

Graph

Absolute values for 0001178879, Amicus Therapeutics INC

  xvar xval
0 AssetsCurrent 391,965,000
1 IntangibleAssetsNetIncludingGoodwill 220,797,000
2 PropertyPlantAndEquipmentNet 9,062,000
3 remainder_Assets 5,200,000
4 LiabilitiesCurrent 70,040,000
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 117,533,993
9 ResearchAndDevelopmentExpense 192,034,223
10 remainder_Expenses 493,885,589
11 remainder_Revenues 26,158,462
12 remainder_NetIncome -16,463,177
13 remainder_ComprehensiveNetIncome 2,158,256
  yvar yval
0 Assets 627,024,000
1 Liabilities 70,040,000
2 Expenses 803,453,805
3 Revenues 26,158,462
4 StockholdersEquity 556,984,000
5 NetIncome -793,758,520
6 ComprehensiveNetIncome -792,679,392
7 BaseVar 772,648,850
8 EconomicCapitalRatiobeforeLimitedLiability 1.21
9 EconomicCapitalRatio 2.46

Edgar->Model Mapping

Feature Distribution

Change over Time